Our scalable bioreactor systems are GMP-aligned, process-intensified cultivation platforms purpose-built for end-to-end mRNA vaccine manufacturing. Optimized for high-density microbial fermentation and large-scale plasmid DNA amplification, the systems deliver exceptional process reproducibility and stable strain performance to support mRNA vaccine upstream production, covering laboratory process development, pilot scale-up validation, and commercial mass manufacturing campaigns.
Engineered with consistent scale-up fluid dynamics, the bioreactor platforms feature high-efficiency oxygen transfer, uniform mixing geometry, and precisely controlled low-shear operation. Advanced closed-loop cascade regulation of temperature, pH, dissolved oxygen and programmable feeding strategies ensures stable microbial growth and continuous plasmid replication across variable working volumes. The scale-consistent design eliminates process deviation during capacity expansion, enabling reliable, loss-free technology transfer from bench scale to industrial production.
Constructed with premium 316L biocompatible stainless steel, all product-contact surfaces adopt mirror polishing, seamless welding and dead-space-free structural layout. The fully enclosed sterile configuration supports automated CIP/SIP cycles, effectively eliminating cross-contamination and residual impurities throughout plasmid propagation workflows. Integrated high-precision sensor suites, real-time process interlocks and full data traceability comply strictly with cGMP, FDA and EMA standards, supporting complete process validation and regulatory filing for mRNA vaccine products.
Designed with modular and flexible system architecture, our scalable bioreactor solutions accommodate rapid process iteration, strain switching and phased production capacity expansion. Featuring intelligent automated operation, minimal manual intervention and long-term operational stability, the systems lower batch variability and overall manufacturing costs. They provide a robust, future-proof upstream foundation for standardized, high-yield and large-scale commercial mRNA vaccine production lines.
